Search clinical trials for: BIND-014 (Docetaxel Nanoparticles for Injectable Suspension)
Total 73 results
-
BIND TherapeuticsCompletedSquamous Cell Non-small Cell Lung Cancer | KRAS Positive Patients With Non-small Cell Lung CancerUnited States, Russian Federation
-
BIND TherapeuticsTerminatedCervical Cancer | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Urothelial CarcinomaRussian Federation, United States
-
NantBioScience, Inc.WithdrawnNeoplastic DiseaseUnited States
-
Point BiomedicalCompletedCoronary Artery DiseaseUnited States
-
Point BiomedicalTerminatedCoronary Artery Disease | HealthyUnited States
-
Point BiomedicalCompletedCoronary Artery DiseaseUnited States
-
Point BiomedicalCompletedCoronary Artery DiseaseUnited States
-
Point BiomedicalTerminatedCoronary Artery DiseaseUnited States
-
Point BiomedicalCompletedCoronary Artery Disease | HealthyUnited States
-
Mast Therapeutics, Inc.CompletedAdvanced CancerUnited States, Argentina, Estonia
-
Lantheus Medical ImagingCompletedVentricular Ejection FractionUnited States
-
Veeda OncologyCelgene CorporationCompletedMetastatic Breast CancerUnited States
-
Zafgen, Inc.TerminatedObesity | Type 2 DiabetesAustralia
-
Zafgen, Inc.CompletedObesity | Prader-Willi Syndrome | Over-weightUnited States
-
Zafgen, Inc.TerminatedObesity | Prader-Willi SyndromeUnited States
-
Sorrento Therapeutics, Inc.CompletedMetastatic Breast Cancer | Locally Recurrent Breast CancerUnited States, Georgia, Moldova, Republic of, Romania, Serbia, Singapore, Ukraine
-
Veeda OncologyBayer; Celgene CorporationTerminated
-
US Oncology ResearchUniversity of Southern California; Celgene CorporationCompleted
-
University of British ColumbiaUnknown
-
NanOlogy, LLCUS Biotest, Inc.WithdrawnKidney Cancer | Renal Cell Carcinoma | Renal Cell Cancer | Adenocarcinoma of Kidney | Adenocarcinoma, Renal
-
Eagle Pharmaceuticals, Inc.TerminatedDrug Toxicity Psychotropic Agents PsychostimulantsUnited States
-
Eagle Pharmaceuticals, Inc.Quintiles, Inc.Completed
-
Zafgen, Inc.Completed
-
Oakwood Laboratories, LLCCompletedProstate CancerUnited States
-
Hongqian GuoActive, not recruitingNeoadjuvant Therapy \ High Risk Prostate Cancer \ DocetaxelChina
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
University of ZurichSwiss HIV Cohort StudyRecruiting
-
Eagle Pharmaceuticals, Inc.CompletedPharmacokineticsUnited States
-
Alkermes, Inc.Completed
-
Ohio State University Comprehensive Cancer CenterCelgene Corporation; National Comprehensive Cancer NetworkCompleted
-
Zafgen, Inc.CompletedObesity | Craniopharyngioma | Over-weight | Hypothalamic InjuryUnited States, Australia
-
Pierre PandinCompleted
-
Universiti Kebangsaan Malaysia Medical CentreCompletedPreoperative AnxietyMalaysia
-
Rhode Island HospitalNational Institute on Drug Abuse (NIDA); Alkermes, Inc.Completed
-
Duke UniversityCelgene CorporationTerminatedMetastatic Breast CancerUnited States, China
-
Duke UniversityAlkermes, Inc.; Laura and John Arnold Foundation; FHR (Fellowship Health Resources... and other collaboratorsCompletedOpioid-Related DisordersUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.FHI 360CompletedContraceptionDominican Republic
-
Yuhong LiCompleted
-
Nang Kuang Pharmaceutical Co., Ltd.RecruitingPain, PostoperativeTaiwan
-
Alkermes, Inc.CompletedOpiate DependenceUnited States
-
Alkermes, Inc.CompletedOpiate DependenceRussian Federation
-
Alkermes, Inc.CompletedAlcohol DependenceUnited States
-
ViiV HealthcareGlaxoSmithKline; Janssen PharmaceuticalsActive, not recruitingHIV Infections | Infection, Human Immunodeficiency VirusGermany, Spain, France, United States, Canada, Australia, Korea, Republic of, Italy, South Africa, Russian Federation, Argentina, Mexico, Sweden
-
University of PennsylvaniaAlkermes, Inc.Recruiting
-
Alkermes, Inc.Completed
-
Alkermes, Inc.Terminated
-
ANRS, Emerging Infectious DiseasesNot yet recruiting